By 2022 March, The Specific Vaccine To Deal With Omicron Will Be Ready!

Pfizer Incorp. is ready to tackle the high contagious Omicron variant by introducing the new dose of vaccine. The authorities have assured the US people that they can get themselves jabbed by the end of this March. An advanced and more powerful COVID-19 vaccine is the most important need of the hour.

By 2022 March, The Specific Vaccine To Deal With Omicron Will Be Ready!

According to the Pfizer CEO, the company is bringing in a developed version of the existing vaccine. In the United States, the Omicron variant is ruling every corner. Hence, it is important to launch an advanced vaccine dose to cover the characteristics of the new variant. The chief of the pharmaceutical company confirms that the new vaccine is likely to come by March. Subject to the inherent risks, the manufacturing process of the vaccines is already in progress.

The Specific Vaccine To Deal With Omicron Will Be Ready!

Centers for Disease Control and Prevention reported that around 95% of the total Covid-19 cases was due to Omicron. The company is trying to improve the properties of the existing vaccines by collaborating with BioNTech of Germany. Moreover, scientists are considering the reaction of the vaccine to the new variants of COVID-19.

Pifer is also of the opinion that the upcoming vaccine will address all the issues arising from different variants of Covid in the future days. Experts say that even a third dose of the existing vaccine will not be able to withstand the power of the newly-found of Omicron variant. Therefore, a developed vaccine is necessary to cover hundreds of people.

The concern of the Chief medical advisor of the White House regarding the new variant is forcing the pharmaceutical companies to focus on developing a new vaccine. Dr. Anthony Fauci expressed the probability of Omicron dominating the Covid variants in the entire United States.

However, there was no mention of the development of a specific vaccine to stop the spread of Omicron. The doctor asks the population to get vaccinated with both the shots for covid-19. In addition to that, they must go for the booster shots for extra protection against the new variant.

Most people think that an additional shot of the existing vaccine can combat the Omicron variant. This virus strain is the primary reason for the increased hospitalization rate in America. As per Pfizer, the new vaccine is going to be a customized one. They are observing the features of the Omicron and the new strains coming one after another. Thus, the scientists are also looking for powerful protection for the Delta variant in the process.

As the third dose is not giving desired results to the Omicron infected patients, Pfizer is thinking about developing something more effective. The prediction of more cases of Omicron covering American and the whole world allows the company to come forward with an improved version of the present vaccine. As per the spokesperson, within 100 days, the company is going to bring a tailor-made vaccine.

The authorities of Pfizer are of the opinion that such a development is in process and will reach the common people within March. However, it requires approval from the US Health Department to be finally launched. With the tailor-made features, such an advanced vaccine will be able to fight against all kinds of new variants besides Omicron. Therefore, the company requests the people to wait for a hundred more days to get a permanent solution for the Covid variants.

Until the new vaccine is not launched, the US people must take the booster shots. The Government must take initiatives to increase the number of health care units to accommodate more people for taking the boosters and vaccines available.

Leave a Comment

About Us

The Nuherald is an ‘everything under one roof’ news portal that provides you with the latest updates and news from the sports, entertainment, tech, health, and business world. We are one among the members of the renowned digital media network, Globe-News Network.

© 2024 TheNuHerald & The GlobeNews Network